Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto Insectarium Monsanto Insectarium The Monsanto Insectarium is an insectarium located within the St. Louis Zoo, in St. Louis, Missouri, United States. David Mason & Associates designed the $4 million, facility which opened in 2000. It houses educational exhibits and an active breeding and research facility. The research facility includes a window to the exhibits area and two-way communications so visitors may watch entomologists work and ask them questions. The facility also includes a geodesic flight dome cage, home to numerous rainforest flowers and butterfly species. The Monsanto Insectarium is open every day except Christmas and New Years days. Admission to the